These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3126456)

  • 21. [Effect of Ca antagonist on prostaglandins and thromboxane B2 in blood and urine].
    Honda M; Takayama R; Fukuda N; Minato M; Watanabe M; Nagashima Y; Soma M; Izumi Y; Shiratsuchi T; Hatano M
    Nihon Jinzo Gakkai Shi; 1986 Jun; 28(6):799-806. PubMed ID: 3534382
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporin A and renal prostaglandin biosynthesis.
    Baxter CR; Duggin GG; Horvath JS; Hall BM; Tiller DJ
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):69-80. PubMed ID: 6382490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroprotection by sucralfate against acetylsalicylic acid in humans. Role of endogenous prostaglandins.
    Konturek SJ; Kwiecień N; Obtułwicz W; Oleksy J
    Scand J Gastroenterol Suppl; 1987; 140():19-22. PubMed ID: 3328281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
    Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
    Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cyclosporine on glomerular prostaglandin production.
    Bunke M; Wilder L; McLeish K
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):646-9. PubMed ID: 3164533
    [No Abstract]   [Full Text] [Related]  

  • 26. [Arachidonic acid metabolism in inflammatory bowel disease--with reference to cyclooxygenase products].
    Yamazaki H; Hiwatashi N; Goto Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Oct; 82(10):2562-8. PubMed ID: 3936952
    [No Abstract]   [Full Text] [Related]  

  • 27. Nasal polyps and their content of arachidonic acid metabolites.
    Nigam S; Kunkel G; Herold D; Baumer FE; Jusuf L
    N Engl Reg Allergy Proc; 1986; 7(2):109-12. PubMed ID: 3475540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.
    Jörstad S; Smeby LC; Wideröe TE; Berg KJ
    Proc Eur Dial Transplant Assoc; 1979; 16():212-7. PubMed ID: 548983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dialyzer membranes on in vitro generation of eicosanoids.
    Schultze G; Wagner K; Neumayer HH; Fitzner R; Molzahn M
    Int J Artif Organs; 1987 Jul; 10(4):275-8. PubMed ID: 3478308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A routine source of human peritoneal macrophages.
    Maddox Y; Foegh M; Zeligs B; Zmudka M; Bellanti J; Ramwell P
    Scand J Immunol; 1984 Jan; 19(1):23-9. PubMed ID: 6701470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eicosanoid release as laboratory indicator of biocompatibility.
    Mahiout A; Jörres A; Schultze G; Meinhold H; Kessel M
    Artif Organs; 1989 Jun; 13(3):251-4. PubMed ID: 2504134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of prostaglandin E2 by macrophages in uraemia.
    Langhoff E; Blaehr H; Ladefoged J
    Nephrol Dial Transplant; 1991; 6(12):966-70. PubMed ID: 1798596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective effect of pulmonary oedema on prostaglandin E2 pharmacokinetics in rat lung.
    Bakhle YS; Grantham CJ
    Biochem Pharmacol; 1985 Dec; 34(24):4325-7. PubMed ID: 3935117
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation.
    Hänsch GM; Seitz M; Betz M
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):317-20. PubMed ID: 3494679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of physico-chemical procedures and biochemical methods for uremia detoxification and construction of modern artificial kidneys].
    Philippson C
    Z Urol Nephrol; 1977 Dec; 70(12):927-37. PubMed ID: 343435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of prostaglandins in pathogenetic mechanisms of the respiratory distress syndrome in premature newborn infants].
    Nabukhotnyĭ TK; Markevich VE; Pabliuk VP
    Akush Ginekol (Mosk); 1989 Sep; (9):65-7. PubMed ID: 2596641
    [No Abstract]   [Full Text] [Related]  

  • 37. A new parallel plate dialyser. II. Description of design and in vitro performance.
    Dawids S; Boe C
    Acta Med Scand Suppl; 1977; 607():17-25. PubMed ID: 270278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of immobilized enzymes in detoxification. I. Study on the physical characteristics of the membrane as a function of the immobilization process].
    Baldini G; Masserini G; Pietta PG; Cremonesi P; Mazzola G; Vecchio G
    Minerva Nefrol; 1979; 26(2):181-4. PubMed ID: 471346
    [No Abstract]   [Full Text] [Related]  

  • 39. A possible new sorbent dialyser for haemodialysis.
    Ioakim P; Rosen D
    Biomed Eng; 1976 Oct; 11(10):351-3. PubMed ID: 974213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer in mice: effects of prednisolone or mepacrine alone and with cytotoxic drugs.
    Bennett A; Melhuish PB; Patel S; Randles H; Stamford IF
    Br J Cancer; 1987 Apr; 55(4):385-8. PubMed ID: 3580263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.